Literature DB >> 17158424

Methylmalonic acid and cognitive function in the Medical Research Council Cognitive Function and Ageing Study.

Cherie McCracken1, Peter Hudson, Richard Ellis, Andrew McCaddon.   

Abstract

BACKGROUND: An elevated blood concentration of homocysteine is an established risk factor for cognitive impairment and dementia, but associations between cognition and methylmalonic acid (MMA), a related metabolic marker of vitamin B-12 deficiency, are less clear.
OBJECTIVE: The aim was to determine the utility of serum MMA and holotranscobalamin as markers of vitamin B-12 status in relation to cognitive function and to investigate their association with discrete cognitive domains.
DESIGN: This was a cross-sectional survey of 84 nondemented elderly participants (aged >69 y) from the Welsh cohort of the Medical Research Council's Cognitive Function and Ageing Study. Cognitive status was determined by Mini-Mental State Examination (MMSE) and the Cognitive Section of the Cambridge Mental Disorders of the Elderly Examination (CAMCOG).
RESULTS: Nearly one-half (43%) of the persons selected had likely metabolically significant vitamin B-12 deficiency. Higher MMA concentrations were associated with lower MMSE scores independent of age and education (P = 0.007). MMA concentration correlated inversely with CAMCOG scores of ideational praxis (P < 0.05) and language comprehension (P < 0.05) and expression (P < 0.01). Serum folate correlated weakly but significantly with language (P < 0.05), remote memory (P < 0.05), and constructional and ideational praxis scores (P < 0.05 and P < 0.01, respectively).
CONCLUSION: The high prevalence of likely metabolically significant vitamin B-12 deficiency in the elderly is associated with lower cognitive function scores and particularly with lower scores of language comprehension and expression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17158424     DOI: 10.1093/ajcn/84.6.1406

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  8 in total

1.  Biochemical indicators of vitamin B12 and folate insufficiency and cognitive decline.

Authors:  Christine C Tangney; Yuxiao Tang; Denis A Evans; Martha Clare Morris
Journal:  Neurology       Date:  2009-01-27       Impact factor: 9.910

2.  Cobalamin deficiency, hyperhomocysteinemia, and dementia.

Authors:  Steven F Werder
Journal:  Neuropsychiatr Dis Treat       Date:  2010-05-06       Impact factor: 2.570

3.  Markers of B-vitamin deficiency and frailty in older women.

Authors:  A M Matteini; J D Walston; M D Fallin; K Bandeen-Roche; W H L Kao; R D Semba; R H Allen; J Guralnik; L P Fried; S P Stabler
Journal:  J Nutr Health Aging       Date:  2008-05       Impact factor: 4.075

Review 4.  Dementia syndromes: evaluation and treatment.

Authors:  Kevin R Scott; Anna M Barrett
Journal:  Expert Rev Neurother       Date:  2007-04       Impact factor: 4.618

5.  Vitamin B12 and cognitive decline.

Authors:  Serdar Tasdemir; Umit Hidir Ulas
Journal:  Ann Indian Acad Neurol       Date:  2015 Oct-Dec       Impact factor: 1.383

6.  Do MCI patients with vitamin B12 deficiency have distinctive cognitive deficits?

Authors:  Dina Silva; Ulrike Albers; Isabel Santana; Margarida Vicente; Isabel Pavão Martins; Ana Verdelho; Manuela Guerreiro; Alexandre de-Mendonça
Journal:  BMC Res Notes       Date:  2013-09-08

7.  Cognitive impact after short-term exposure to different proton pump inhibitors: assessment using CANTAB software.

Authors:  Sanjida Akter; Md Rajib Hassan; Mohammad Shahriar; Nahia Akter; Md Golam Abbas; Mohiuddin Ahmed Bhuiyan
Journal:  Alzheimers Res Ther       Date:  2015-12-27       Impact factor: 6.982

8.  Plasma Methylmalonic Acid Concentration in Folic Acid-Supplemented Depressed Patients with Low or Marginal Vitamin B-12: A Randomized Trial.

Authors:  Ben Carter; Zohra Zenasni; Stuart J Moat; Peter R Hudson; Ian T Russell; Andrew McCaddon
Journal:  J Nutr       Date:  2021-12-03       Impact factor: 4.798

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.